COVID-19 Information & Recommendations for People with Scleroderma
- 3/30 UPDATED Statement COVID-19 (Coronavirus) Information & Recommendations
- 30/3/20 Espanol "COVID-2019 ("Coronavirus") Información y recomendaciones Desde La Fundación de la Esclerodermia Comité de Asesoría Médica y Científica
- 3/27 Webinar Recording: "Staying Well During COVID-19," Tracy Frech, M.D., M.S., University of Utah
- 3/25 Webinar Recording: "Scleroderma Lung Health & COVID-19 with Shervin Assassi, M.D."
- 3/21 Video Forum Recording "Scleroderma & COVID-19: A Conversation with the Experts"
- 3/21 Statement "Important Information Related to COVID-19 and Juvenile Scleroderma
- 3/20 Message from Scleroderma Foundation CEO, Robert J. Riggs
- 3/13 COVID-19 Public Health Advisory
2020 National Patient Education Conference & Kids Get Scleroderma, Too!
- To protect the health of individuals who have scleroderma, the Scleroderma Foundation has cancelled its 2020 National Patient Education Conference and Kids Get Scleroderma, Too! conference scheduled to take place July 17-19 in Bellevue, Washington.
- Individuals who have scleroderma, particularly those who have systemic sclerosis, are immuno-compromised and have a heightened risk for the worst-case symptoms of the coronavirus (COVID-19).
- This decision was taken after thorough review of information available through public health agencies, primarily the Centers for Disease Control & Prevention and the State of Washington Public Health Department.
- In lieu of the eagerly anticipated in-person educational conference and the unique and essential personal connections it provides; the Scleroderma Foundation is developing creative, alternative programming to be announced later.
- A full refund of conference fees will be given automatically the week of March 16-20 to all currently registered to attend.
- Hotel room reservations must be cancelled independently.
- We are pleased to announce that the conference will return to Bellevue, Washington in 2022. The location for the 2021 conference will be announced later this year.
- Video recordings of presentations by scleroderma experts at past Foundation conferences can be found at www.YouTube.com/sclerodermaUS.
Thank you for your understanding.
Who We Are
The Scleroderma Foundation is a federally qualified 501(c)(3) nonprofit dedicated to serving the needs of the scleroderma community. Our primary goal is to raise funds and awareness for our three-fold mission of support, education and research. All donations are qualified charitable donations to the fullest extent of the law. Our federal tax identification number is 52-1375827. All donations are gratefully accepted.
What is Scleroderma?
Scleroderma, or systemic sclerosis, is a chronic connective tissue disease generally classified as one of the autoimmune rheumatic diseases. The word “scleroderma” comes from two Greek words: “sclero” meaning hard, and “derma” meaning skin. Hardening of the skin is one of the most visible manifestations of the disease.
Can’t download It? Have us mail you a copy!
- Important Information Related to COVID-19 and Juvenile Scleroderma
- Spanish Language Version of COVID-19 Statement
- Updated COVID-19 Statement from the Scleroderma Foundation's Medical & Scientific Advisory Board Leadership Committee
- Video: March 21 Video Forum on COVID-19 & Scleroderma
- Video: March 25 Lung Involvement in Scleroderma & COVID-19
- SPIN Invites Individuals with Scleroderma to Share COVID-19 Concerns
- Webinar: STaY Breathing! 3/28, 11 a.m. Eastern
- Sunday Sitdown, Facebook Live: March 29, 1 p.m. Eastern
- Clinical Trial Opportunity
- Safety and Tolerability Study of AVID200, a Novel TGF-beta 1 & 3 Inhibitor, in Patients with Diffuse Cutaneous Systemic Sclerosis
- Advertisement: KD025-209 Study